The Rho Kinases: Critical Mediators of Multiple Profibrotic Processes and Rational Targets for New Therapies for Pulmonary Fibrosis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmacological Reviews

• Publication date

  2015-01-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1124/pr.114.009381PMID 25395505PMCID PMC4279074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

  2014cited by this paper
• Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

  2014cited by this paper
• Fasudil hydrochloride hydrate, a Rho‐kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes

  2014cited by this paper
• Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase

  2014cited by this paper
• Idiopathic pulmonary fibrosis.

  2014cited by this paper
• Host responses in tissue repair and fibrosis.

  2013cited by this paper
• Animal models of fibrotic lung disease.

  2013cited by this paper
• LPA1‐induced cytoskeleton reorganization drives fibrosis through CTGF‐dependent fibroblast proliferation

  2013cited by this paper
• Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case–control study

  2013cited by this paper
• Rho-associated protein kinase inhibition enhances airway epithelial Basal-cell proliferation and lentivirus transduction.

  2013cited by this paper
• Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis.

  2013cited by this paper
• Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells.

  2013cited by this paper
• Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.

  2013cited by this paper
• Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

  2013cited by this paper
• Biomechanical regulation of mesenchymal cell function

  2013cited by this paper
• Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts

  2013cited by this paper
• Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis

  2013cited by this paper
• Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.

  2013cited by this paper
• Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair.

  2013cited by this paper
• An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

  2012cited by this paper
• Mechanisms of fibrosis: therapeutic translation for fibrotic disease

  2012cited by this paper
• Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction.

  2012cited by this paper
• Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

  2012cited by this paper
• Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

  2012cited by this paper
• The mechanical memory of lung myofibroblasts.

  2012cited by this paper
• Fasudil, a Rho-Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

  2012cited by this paper
• Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

  2012cited by this paper
• CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

  2012cited by this paper
• Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection.

  2012cited by this paper
• The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.

  2012cited by this paper
• Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.

  2011cited by this paper
• TGF-β/TGF-β receptor system and its role in physiological and pathological conditions.

  2011cited by this paper
• Role of YAP/TAZ in mechanotransduction

  2011cited by this paper
• Protective and pathogenic functions of macrophage subsets

  2011cited by this paper
• Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.

  2011cited by this paper
• Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage

  2011cited by this paper
• Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.

  2011cited by this paper
• Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.

  2011cited by this paper
• Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.

  2011cited by this paper
• Metchnikoff's policemen: macrophages in development, homeostasis and regeneration.

  2011cited by this paper
• Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression

  2010cited by this paper
• Linking actin dynamics and gene transcription to drive cellular motile functions

  2010cited by this paper
• The pathogenesis of idiopathic pulmonary fibrosis

  2010cited by this paper
• Effect of ROCK Inhibitor Y-27632 on Normal and Variant Human Embryonic Stem Cells (hESCs) In Vitro: Its Benefits in hESC Expansion

  2010cited by this paper
• MMP expression and abnormal lung permeability are important determinants of outcome in IPF

  2009cited by this paper
• Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta.

  2009cited by this paper
• Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.

  2009cited by this paper
• Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice.

  2009cited by this paper
• Statins inhibit Rho kinase activity in patients with atherosclerosis.

  2009cited by this paper
• Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).

  2009cited by this paper
• Cellular and molecular basis of pulmonary arterial hypertension.

  2009cited by this paper
• Endothelial contractile cytoskeleton and microvascular permeability.

  2009cited by this paper
• Apoptosis in Pulmonary Fibrosis: Too Much or Not Enough?

  2008cited by this paper
• The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

  2008cited by this paper
• Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy.

  2008cited by this paper
• Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis.

  2008cited by this paper
• Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation

  2008cited by this paper
• Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.

  2008cited by this paper
• Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.

  2008cited by this paper
• Early events in the recognition of danger signals after tissue injury

  2008cited by this paper
• The ROCK Inhibitor Y-27632 Enhances the Survival Rate of Human Embryonic Stem Cells Following Cryopreservation

  2008cited by this paper
• Faculty Opinions recommendation of Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix.

  2008cited by this paper
• Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis

  2008cited by this paper
• TEAD mediates YAP-dependent gene induction and growth control.

  2008cited by this paper
• Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP*

  2008cited by this paper
• Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell‐derived neural precursors

  2008cited by this paper
• Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

  2007cited by this paper
• A ROCK inhibitor permits survival of dissociated human embryonic stem cells

  2007cited by this paper
• New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma

  2007cited by this paper
• Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis.

  2007cited by this paper
• Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix

  2007cited by this paper
• Elucidation of a universal size-control mechanism in Drosophila and mammals.

  2007cited by this paper
• Molecular targets in pulmonary fibrosis: the myofibroblast in focus.

  2007cited by this paper
• Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis

  2007cited by this paper
• A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage.

  2007cited by this paper
• A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats.

  2007cited by this paper
• Fasudil Attenuates Myocardial Fibrosis in Association With Inhibition of Monocyte/Macrophage Infiltration in the Heart of DOCA/Salt Hypertensive Rats

  2007cited by this paper
• Rho Kinase (ROCK) Inhibitors

  2007influential reference
• Transforming growth factor‐β and substrate stiffness regulate portal fibroblast activation in culture

  2007cited by this paper
• Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

  2007cited by this paper
• Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.

  2006cited by this paper
• Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.

  2006cited by this paper
• Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.

  2006cited by this paper
• Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice.

  2006cited by this paper
• Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis

  2006cited by this paper
• Rho and ROCK Signaling in VEGF‐Induced Microvascular Endothelial Hyperpermeability

  2006cited by this paper
• Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.

  2006cited by this paper
• Physiological role of ROCKs in the cardiovascular system.

  2006cited by this paper
• Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.

  2005cited by this paper
• Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis.

  2005cited by this paper
• Inhibition of Rho Kinase (ROCK) Leads to Increased Cerebral Blood Flow and Stroke Protection

  2005cited by this paper
• Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1+/− Haploinsufficient Mice

  2005cited by this paper
• Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.

  2005cited by this paper
• Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.

  2005cited by this paper
• Perspective Article: Tissue repair, contraction, and the myofibroblast

  2005cited by this paper
• Rho GTPases, statins, and nitric oxide.

  2005cited by this paper
• ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles

  2005cited by this paper
• Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632.

  2005cited by this paper
• Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL‐induced apoptosis

  2004cited by this paper
• Toll-like receptor control of the adaptive immune responses

  2004cited by this paper

• Esketamine Alleviates Postoperative Cognitive Dysfunction via Rock2/Add1 Signaling Pathway in Aged Mice

  2026cites this paper
• Androgen dysregulates the follicular extracellular matrix and increases pro-fibrotic gene expression in the mouse ovary.

  2026cites this paper
• Discovery of triazolyl azabicyclo[3.1.0]hexane derivative as an autotaxin inhibitors for the treatment of pulmonary fibrosis.

  2026cites this paper
• Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel Pathways

  2026cites this paper
• Inhibition of ROCK2 impedes osteoclastogenesis through Src-Ca2+-NFATc1 signaling pathway and alleviates ovariectomy-induced bone loss.

  2026cites this paper
• Four Novel Rho‐associated Coiled‐coil Protein Kinase 1 Inhibitors Suppressing Cytoskeleton and Movement in Breast Cancer Cells

  2025cites this paper
• 4-Anilinoquinolinylchalcone derivatives mediate antifibrotic effects through ERK/MRTF—a signaling pathway crosstalk

  2025cites this paper
• A particle of concern: explored and proposed underlying mechanisms of microplastic-induced lung damage and pulmonary fibrosis

  2025cites this paper
• Human heart-on-a-chip model emulates structural and functional characteristics of diastolic dysfunction and reveals a beneficial role for senolytics.

  2025cites this paper
• Modern-Era Challenges in the Clinical Management of Graft-Versus-Host Disease.

  2025cites this paper
• Identification of Novel Imidazo[1,2-b]pyridazine Derivatives as Selective ROCK2 Inhibitors for the Treatment of Pulmonary Fibrosis.

  2025cites this paper
• Inhibition of Rho-Associated Kinases ROCK1 and ROCK2 as a Therapeutic Strategy to Reactivate the Repressed FXN Gene in Friedreich Ataxia

  2025cites this paper
• Pharmacological Profile and Therapeutic Evaluation of ROC-101, a Potent and Selective ROCK Inhibitor, in Arterial Hypertension and Pulmonary Fibrosis.

  2025cites this paper
• Pharmacological targeting of ECM homeostasis, fibroblast activation and invasion for the treatment of pulmonary fibrosis

  2025cites this paper
• Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages

  2025cites this paper
• Angiopoietin-like protein 7: A narrative review and its potential roles in post-myocardial infarction fibrosis

  2025cites this paper
• Cellular Therapy for Systemic Autoimmune Diseases: New Opportunities for Future Research and Interdisciplinary Collaboration

  2025cites this paper
• Prostaglandin F2α exacerbated dry eye by promoting lacrimal gland fibrosis progression through the activation of the RhoA/ROCKs signaling pathway.

  2025cites this paper
• Calcium Signaling Dynamics in Vascular Cells and Their Dysregulation in Vascular Disease

  2025cites this paper
• Three‐Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients

  2025cites this paper
• Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease

  2025cites this paper
• Mechanical forces drive degenerative spine disease through ROCK signalling

  2025cites this paper
• Rho-kinase inhibition reduces subretinal fibrosis

  2025cites this paper
• ROCK-dependent mechanotransduction of macroscale forces drives fibrosis in degenerative spinal disease

  2025cites this paper
• Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis

  2025cites this paper
• Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis

  2024cites this paper
• THE CURRRENT LANDSCAPE OF ANTIFIBROTIC THERAPY ACROSS DIFFERENT ORGANS: A SYSTEMATIC APPROACH.

  2024cites this paper
• The role of fibrosis in endometriosis: a systematic review

  2024cites this paper
• Exploring therapeutic targets for molecular therapy of idiopathic pulmonary fibrosis

  2024cites this paper
• Non-Muscle Myosin II A: Friend or Foe in Cancer?

  2024cites this paper
• ROCK and the actomyosin network control biomineral growth and morphology during sea urchin skeletogenesis

  2024cites this paper
• Evidence for a lipofibroblast-to-Cthrc1+ myofibroblast reversible switch during the development and resolution of lung fibrosis in young mice

  2024cites this paper
• CircPWWP2A promotes renal interstitial fibrosis through modulating miR-182/ROCK1 axis

  2024cites this paper
• Pharmacological targets and validation of remdesivir for the treatment of COVID-19-associated pulmonary fibrosis: A network-based pharmacology and bioinformatics study

  2024cites this paper
• Y-27632 enables long-term expansion of mouse submandibular gland epithelial cells via inactivation of TGF-β1/CTGF/p38 and ROCK2/JNK signaling pathway.

  2024cites this paper
• Novel Small Molecule ROCK2 Inhibitor GNS-3595 Attenuates Pulmonary Fibrosis in Preclinical Studies.

  2024cites this paper
• Paving the ROCKy Path to Novel Antifibrotics

  2024cites this paper
• Modelling and targeting mechanical forces in organ fibrosis

  2024cites this paper
• SLIT3 promotes cardiac fibrosis and differentiation of cardiac fibroblasts by RhoA/ROCK1 signaling pathway

  2024cites this paper
• Novel therapeutic strategy for intractable keloids: Suppression of intracellular mechanotransduction and actin polymerisation via Rho-kinase pathway inhibition.

  2024cites this paper
• Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model.

  2024cites this paper
• Mechanotransduction and the extracellular matrix: Key drivers of lung pathologies and drug responsiveness.

  2024cites this paper
• Mechanisms Regulating Mitochondrial Transfer in Human Corneal Epithelial Cells

  2024cites this paper
• Role and targeting of the AGC kinase family in pulmonary fibrosis (Review).

  2024cites this paper
• Anti-fibrogenic effect of umbilical cord–derived mesenchymal stem cell–conditioned media in human esophageal fibroblasts

  2024cites this paper
• The potential role of miRNA in regulating macrophage polarization

  2023cites this paper
• Recent Advancement in Elimination Strategies and Potential Rejuvenation Targets of Senescence

  2023cites this paper
• Role of integrins in the development of fibrosis in the trabecular meshwork

  2023cites this paper
• scBeacon: single-cell biomarker extraction via identifying paired cell clusters across biological conditions with contrastive siamese networks

  2023cites this paper
• Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis

  2023cites this paper
• Selectivity matters: selective ROCK2 inhibitor ameliorates established liver fibrosis via targeting inflammation, fibrosis, and metabolism

  2023cites this paper
• Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways.

  2023cites this paper
• Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis

  2023cites this paper
• Understanding and treatment of cutaneous graft-versus-host-disease

  2023cites this paper
• Repurposing small molecules for Nephronophthisis and related renal ciliopathies.

  2023cites this paper
• Investigational drugs for the treatment of scleroderma: what’s new?

  2023cites this paper
• FDCA Attenuates Neuroinflammation and Brain Injury after Cerebral Ischemic Stroke.

  2023cites this paper
• Discovery of indoline-based derivatives as effective ROCK2 inhibitors for the potential new treatment of idiopathic pulmonary fibrosis.

  2023cites this paper
• Idiopathic Pulmonary Fibrosis.

  2023cites this paper
• Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives.

  2023cites this paper
• A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis

  2023cites this paper
• Tuftelin1 drives experimental pulmonary fibrosis progression by facilitating stress fiber assembly

  2023cites this paper
• Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitors.

  2023cites this paper
• NFATc3 Promotes Pulmonary Inflammation and Fibrosis by Regulating Production of CCL2 and CXCL2 in Macrophages

  2023cites this paper
• An update on current and emerging drug treatments for idiopathic pulmonary fibrosis

  2023cites this paper
• Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies.

  2023cites this paper
• VGLL3 is a mechanosensitive protein that promotes cardiac fibrosis through liquid–liquid phase separation

  2023cites this paper
• Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

  2023cites this paper
• Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present)

  2022cites this paper
• Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-β signaling

  2022cites this paper
• The anti-asthmatic potential of Rho-kinase inhibitor hydroxyfasudil in the model of experimentally induced allergic airway inflammation.

  2022cites this paper
• Role of Immune Cells in the Initiation and Progression of Pulmonary Fibrosis.

  2022cites this paper
• Misbehaving Guests in the Right Ventricle: Macrophage–NLRP3 Activation in Pulmonary Hypertension

  2022cites this paper
• From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

  2022influential citation
• Evaluating a Specific Dual ROCK Inhibitor against Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats.

  2022cites this paper
• MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer

  2022cites this paper
• Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis

  2022cites this paper
• Rho Kinases in Embryonic Development and Stem Cell Research

  2022cites this paper
• Belumosudil, ROCK2-Specific Inhibitor, alleviates cardiac fibrosis by inhibiting cardiac fibroblasts activation.

  2022cites this paper
• Uncaria Rhynchophylla attenuates angiotensin Ⅱ-induced myocardial fibrosis via suppression of the RhoA/ROCK1 pathway.

  2022cites this paper
• Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3

  2022cites this paper
• Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

  2021cites this paper
• ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension

  2021cites this paper
• A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings

  2021cites this paper
• Molecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review

  2021cites this paper
• Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways

  2021cites this paper
• Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review

  2021cites this paper
• Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

  2021cites this paper
• Exogenous extracellular matrix proteins decrease cardiac fibroblast activation in stiffening microenvironment through CAPG

  2021cites this paper
• New Insights into the Hippo/YAP Pathway in Idiopathic Pulmonary Fibrosis.

  2021cites this paper
• Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?

  2021cites this paper
• Targeting SerpinE1 reverses cellular features of Hutchinson-Gilford progeria syndrome

  2021cites this paper
• ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis

  2021cites this paper
• Rho/ROCK Inhibition Promotes TGF-β3-Induced Tenogenic Differentiation in Mesenchymal Stromal Cells

  2021cites this paper
• Dexmedetomidine alleviates cardiomyocyte apoptosis and cardiac dysfunction may be associated with inhibition of RhoA/ROCK pathway in mice with myocardial infarction

  2021cites this paper
• Serine-Threonine Kinase inhibition as antifibrotic therapy: TGF-β and ROCK inhibitors.

  2021cites this paper
• The Design, Synthesis and Evaluation of Rho-kinase Inhibitory Activity of 4-aryl-thiazole-2-amines

  2021cites this paper
• Title Rho signaling research: history, current status and future directions

  2021cites this paper
• ROCK inhibitor attenuates carbon blacks‐induced pulmonary fibrosis in mice via Rho/ROCK/NF‐kappa B pathway

  2021cites this paper
• ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease.

  2021cites this paper